Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / VTGN - VistaGen Therapeutics Inc. (VTGN) CEO Shawn Singh on Q3 2022 Results - Earnings Call Transcript

VTGN - VistaGen Therapeutics Inc. (VTGN) CEO Shawn Singh on Q3 2022 Results - Earnings Call Transcript

VistaGen Therapeutics Inc.
VistaGen Therapeutics, Inc. (VTGN) Q3 2022 Earnings Conference Call February 10, 2022 17:00 ET Company Participants Mark Flather - Vice President, Investor Relations Shawn Singh - Chief Executive Officer Jerry Dotson - Chief Financial Officer Mark Smith - Chief Medical Officer Conference Call Participants Andrew Tsai - Jefferies Lachlan Hanbury-Brown - William Blair Luke Herrmann - Baird Joanne Lee - Maxim Group Presentation Operator Greetings and welcome to VistaGen Therapeutics’ Third Quarter of Fiscal Year 2022 Results Conference Call. [Operator instructions] And please note that this conference is being recorded. I will now turn the conference over to your host Mark Flather, Vice President of Investor Relations. Thank you. You may begin. Mark Flather Thank you, John. Hello and welcome to VistaGen’s conference call covering our fiscal year 2022 third quarter financial results, recent accomplishments and anticipated milestones. I am Mark Flather, Vice President of Investor Relations at VistaGen. Thank

For further details see:

VistaGen Therapeutics, Inc. (VTGN) CEO Shawn Singh on Q3 2022 Results - Earnings Call Transcript
Stock Information
Company Name: VistaGen Therapeutics Inc.
Stock Symbol: VTGN
Market: NASDAQ
Website: vistagen.com
Menu
VTGN VTGN Quote VTGN Short VTGN News VTGN Articles VTGN Message Board
Get VTGN Alerts

News, Short Squeeze, Breakout and More Instantly...